Alice Burchett

Alice Burchett

Auto-generated profile, based on publicly available information

Alice Burchett

Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2024 in Chemical Science
Verified
Journal Article
Open access
PDF file
JMJaneala J. Morsby
Janeala J. Morsby
ZZZhumin Zhang
Zhumin Zhang
ABAlice Burchett
Alice Burchett
MDMeenal Datta
Meenal Datta
BSBradley Smith
Bradley Smith
Fluorescent molecular probes that report nitroreductase activity have promise as imaging tools to elucidate the biology of hypoxic cells and report the past hypoxic history of biomedical tissue. This study describes the synthesis and validation of a “first-in-class” ratiometric, hydrophilic near-infrared fluorescent molecular probe for imaging hypoxia-induced nitroreductase activity in 2D cell culture monolayers and 3D multicellular tumor spheroids. The probe's molecular structure is charge-balanced and the change in ratiometric signal is based on Förster Resonance Energy Transfer (FRET) from a deep-red, pentamethine cyanine donor dye (Cy5, emits ∼660 nm) to a linked near-infrared, heptamethine cyanine acceptor dye (Cy7, emits ∼780 nm). Enzymatic reduction of a 4-nitrobenzyl group on the Cy7 component induces a large increase in Cy7/Cy5 fluorescence ratio. The deep penetration of near-infrared light enables 3D optical sectioning of intact tumor spheroids, and visualization of individual hypoxic cells (i.e., cells with raised Cy7/Cy5 ratio) as a new way to study tumor spheroids. Beyond preclinical imaging, the near-infrared fluorescent molecular probe has high potential for ratiometric imaging of hypoxic tissue in living subjects.

10 October 2024 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
HSHimani Sharma
Himani Sharma
VYVivek Yadav
Vivek Yadav
ABAlice Burchett
Alice Burchett
TSTiger Shi
Tiger Shi
SSSatyajyoti Senapati
Satyajyoti Senapati
HCHsueh-Chia Chang
Hsueh-Chia Chang

2 January 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MZMaksym Zarodniuk
Maksym Zarodniuk
AWAnna Wenninger
Anna Wenninger
JNJulian Najera
Julian Najera
JLJihaeng Lee
Jihaeng Lee
JMJack Markillie
Jack Markillie
CPChristopher Patzke
Christopher Patzke
Mass effect, characterized by the compression and deformation of neural tissue from space-occupying lesions, can lead to debilitating neurological symptoms and poses a significant clinical challenge. In the primary brain tumor glioblastoma (GBM), we have shown previously that compressive solid stress originating from the growing tumor reduces cerebral blood flow, leading to neuronal loss, increased functional impairment, and poor clinical outcomes. However, the direct effects of compression on neurons and the underlying biophysical mechanisms are poorly understood. Here, using multiscale compression systems and physiologically relevant in vitro and in vivo models, we find that chronic mechanical compression induces neuronal apoptosis and loss of synaptic puncta, leading to disrupted neural network activity, as assessed by calcium imaging. This is accompanied by increased HIF-1 signaling and upregulation of downstream stress-adaptive genes in neurons. We further show that chronic compression triggers AP-1–driven gene expression in glial cells, promoting a neuroinflammatory response. Together, these findings reveal that solid stress directly contributes to neuronal dysfunction and inflammation caused by GBM by activating distinct pathways that can be targeted in future studies for neuroprotection.

10 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAlice Burchett Darantiere
Alice Burchett Darantiere
MZMaksym Zarodniuk
Maksym Zarodniuk
SGShelby Giza
Shelby Giza
JRJason Rexroat
Jason Rexroat
PKPaul Kuehl
Paul Kuehl
MDMeenal Datta
Meenal Datta
Glioblastoma (GBM) is an incurable brain cancer characterized by its highly immunosuppressive tumor microenvironment and aggressive malignant features that resist treatment. To overcome limitations of Earth-based models (sedimentation and disaggregation) and leverage the unique biological effects of space (accelerated disease progression and immune dysregulation), we developed a panel of GBM-myeloid organoids for extended culture on the International Space Station. After 40 days, the spaceflight-grown organoids had more uniform and reproducible morphology compared to identical ground controls. Organoids containing GBM cells + monocytes had increased expression of chronic innate inflammation, adaptive immune activation, and tissue and vascular remodeling-associated genes. There was an increase in organization of gene expression patterns, with mesenchymal-related genes enriched in the core and inflammation-related genes enriched at the periphery, mimicking GBM tumor architecture. Secretomics confirmed the generation of more immunosuppressive organoids, with enrichment of proteins associated with more aggressive disease, including CXCL12 and LOX-1. GBM co-culture organoids thus had enhanced transcriptomic, proteomic, and architectural features when grown in microgravity that are associated with worse patient outcomes from retrospective data. Infrared laser scanning microscopy confirmed spatial chemical gradients for DNA, protein, and lipid species in both space- and terrestrially-grown organoids. In summary, we present not only a novel and superior model of glioblastoma for more relevant basic, mechanistic, and translational research, but also demonstrate methods to acquire high-quality and diverse data from organoids compatible with the unique experimental constraints of biological research in space to help establish a working model for orbital oncology.

17 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAlice Burchett
Alice Burchett
HCHao Chen
Hao Chen
JNJulian Najera
Julian Najera
SHScott Howard
Scott Howard
MDMeenal Datta
Meenal Datta
Macrophages comprise a significant portion of the glioblastoma tumor microenvironment and are essential in promoting immunosuppression and tumor progression. Solid tumors such as glioblastoma generate solid stress as they expand, creating a compressive microenvironment for mechanosensitive immune cells including macrophages. Macrophages are known to respond to various mechanical stimuli but have not yet been studied in the context of chronic compression observed in growing tumors. Here, we used a custom in vitro compression system to elucidate the effects of compressive solid stress on murine macrophages. We found that macrophages have significant morphological, transcriptional, metabolic, and functional responses to compression. These changes corresponded to both canonical pro- and anti-inflammatory macrophage states. The gene expression signatures of compressed macrophages more closely resembled those of glioma-associated macrophages known to be associated with worse patient outcomes. These results indicate that compression alone, independent from tumor cell-derived biochemical factors, may contribute to the pathological tumor-associated macrophage phenotype. This could represent a vicious cycle of tumor immunomechanics and mechano-immunology. Targeting solid stress in tumors or the response to solid stress by macrophages may interrupt this feedback loop to help normalize the tumor immune microenvironment and improve glioblastoma response to immunotherapy.